Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.

Han X, Zhao J, Ruddy KJ, Lin CC, Sineshaw HM, Jemal A.

PLoS One. 2018 Jun 13;13(6):e0198771. doi: 10.1371/journal.pone.0198771. eCollection 2018.

2.

What Can We Learn From Menstrual Patterns After Treatment for HER2-Positive Breast Cancer?

Cathcart-Rake E, Gast KC, Ruddy KJ.

J Natl Cancer Inst. 2018 Jun 5. doi: 10.1093/jnci/djy092. [Epub ahead of print] No abstract available.

PMID:
29878141
3.

Association of Uveitis and Macular Edema With Anastrozole Therapy.

Sathiamoorthi S, Ruddy KJ, Bakri SJ.

JAMA Ophthalmol. 2018 Jul 1;136(7):837-839. doi: 10.1001/jamaophthalmol.2018.1700. No abstract available.

PMID:
29800041
4.

Childbirth after adolescent and young adult cancer: a population-based study.

Nichols HB, Anderson C, Ruddy KJ, Black KZ, Luke B, Engel SM, Mersereau JE.

J Cancer Surviv. 2018 May 22. doi: 10.1007/s11764-018-0695-7. [Epub ahead of print]

PMID:
29785559
5.

Assessing Unmet Information Needs of Breast Cancer Survivors: Exploratory Study of Online Health Forums Using Text Classification and Retrieval.

McRoy S, Rastegar-Mojarad M, Wang Y, Ruddy KJ, Haddad TC, Liu H.

JMIR Cancer. 2018 May 15;4(1):e10. doi: 10.2196/cancer.9050.

6.

Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.

Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, Jemal A, Duma N, Haddad TC, Lemaine V, Ghosh K, Hieken TJ, Hunt K, Vachon C, Gross C, Shah ND.

J Natl Compr Canc Netw. 2018 May;16(5):526-534. doi: 10.6004/jnccn.2018.7001.

PMID:
29752327
7.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, Bolla MK, Brenner H, Chang-Claude J, Cora R, Couch FJ, Cuk K, Devilee P, Easton DF, Eccles DM, Eilber U, Hartikainen JM, Heikkilä P, Holleczek B, Hooning MJ, Jones M, Keeman R, Mannermaa A, Martens JWM, Muranen TA, Nevanlinna H, Olson JE, Orr N, Perez JIA, Pharoah PDP, Ruddy KJ, Saum KU, Schoemaker MJ, Seynaeve C, Sironen R, Smit VTHBM, Swerdlow AJ, Tengström M, Thomas AS, Timmermans AM, Tollenaar RAEM, Troester MA, van Asperen CJ, van Deurzen CHM, Van Leeuwen FF, Van't Veer LJ, García-Closas M, Figueroa JD.

Sci Rep. 2018 Apr 26;8(1):6574. doi: 10.1038/s41598-018-23733-4.

8.

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).

Freedman RA, Dockter TJ, Lafky JM, Hurria A, Muss HJ, Cohen HJ, Jatoi A, Kemeny MM, Ruddy KJ.

Oncologist. 2018 Apr 19. pii: theoncologist.2018-0033. doi: 10.1634/theoncologist.2018-0033. [Epub ahead of print]

PMID:
29674441
9.

Preventing Today's Survivors of Breast Cancer From Becoming Tomorrow's Cardiac Patients.

Nowsheen S, Duma N, Ruddy KJ.

J Oncol Pract. 2018 Apr;14(4):213-214. doi: 10.1200/JOP.18.00130. No abstract available.

PMID:
29641946
10.

Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy.

O'Sullivan CC, Van Houten HK, Sangaralingham LR, Leal AD, Shinde S, Liu H, Ettinger D, Loprinzi CL, Ruddy KJ.

J Natl Compr Canc Netw. 2018 Mar;16(3):294-299. doi: 10.6004/jnccn.2017.7043.

PMID:
29523668
11.

Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.

Gast KC, Viscuse PV, Nowsheen S, Haddad TC, Mutter RW, Wahner Hendrickson AE, Couch FJ, Ruddy KJ.

Curr Treat Options Cardiovasc Med. 2018 Mar 1;20(2):18. doi: 10.1007/s11936-018-0609-z. Review.

PMID:
29497862
12.

Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.

Lilyquist J, Ruddy KJ, Vachon CM, Couch FJ.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):380-394. doi: 10.1158/1055-9965.EPI-17-1144. Epub 2018 Jan 30.

PMID:
29382703
13.

Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary Tale.

Giridhar KV, Viscuse PV, Loprinzi CL, Ruddy KJ.

J Natl Cancer Inst. 2018 Jun 1;110(6):551-552. doi: 10.1093/jnci/djx294. No abstract available.

PMID:
29361012
14.

Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience.

Jethwa KR, Kahila MM, Mara KC, Harmsen WS, Routman DM, Pumper GM, Corbin KS, Sloan JA, Ruddy KJ, Hieken TJ, Park SS, Mutter RW.

Breast Cancer Res Treat. 2018 May;169(1):189-196. doi: 10.1007/s10549-018-4665-6. Epub 2018 Jan 18.

PMID:
29349713
15.

Biology of premature ageing in survivors of cancer.

Cupit-Link MC, Kirkland JL, Ness KK, Armstrong GT, Tchkonia T, LeBrasseur NK, Armenian SH, Ruddy KJ, Hashmi SK.

ESMO Open. 2017 Dec 18;2(5):e000250. doi: 10.1136/esmoopen-2017-000250. eCollection 2017. Review.

16.

Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer.

Nowsheen S, Viscuse PV, O'Sullivan CC, Sandhu NP, Haddad TC, Blaes A, Klemp J, Nhola L, Herrmann J, Ruddy KJ.

Curr Breast Cancer Rep. 2017 Sep;9(3):173-182. doi: 10.1007/s12609-017-0249-4. Epub 2017 Jul 14.

PMID:
29225726
17.

Disparities in Adjuvant Endocrine Therapy.

Cathcart-Rake EJ, Ruddy KJ.

J Natl Compr Canc Netw. 2017 Dec;15(12):1559-1561. doi: 10.6004/jnccn.2017.7057. No abstract available.

PMID:
29223993
18.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

PMID:
29092024
19.

Association analysis identifies 65 new breast cancer risk loci.

Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal L, McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittomäki K, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Arun B, Auer PL, Bacot F, Barrdahl M, Baynes C, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Brinton L, Broberg P, Brock IW, Broeks A, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Butterbach K, Cai Q, Cai H, Caldés T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL; NBCS Collaborators, Collée M, Conroy DM, Cordina-Duverger E, Cornelissen S, Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gaborieau V, Gabrielson M, Gago-Dominguez M, Gao YT, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hamel N, Hankinson S, Harrington P, Hart SN, Hartikainen JM, Hartman M, Hein A, Heyworth J, Hicks B, Hillemanns P, Ho DN, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kasuga Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Kosma VM, Kristensen VN, Krüger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Menéndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Ruddy KJ, Rüdiger T, Rudolph A, Ruebner M, Rutgers EJT, Saloustros E, Sandler DP, Sangrajrang S, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets A, Sohn C, Southey MC, Spinelli JJ, Stegmaier C, Stewart-Brown S, Stone J, Stram DO, Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengström M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Thöne K, Tollenaar RAEM, Tomlinson I, Tong L, Torres D, Truong T, Tseng CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E; ABCTB Investigators; ConFab/AOCS Investigators, Lakhani SR, Antoniou AC, Droit A, Andrulis IL, Amos CI, Couch FJ, Pharoah PDP, Chang-Claude J, Hall P, Hunter DJ, Milne RL, García-Closas M, Schmidt MK, Chanock SJ, Dunning AM, Edwards SL, Bader GD, Chenevix-Trench G, Simard J, Kraft P, Easton DF.

Nature. 2017 Nov 2;551(7678):92-94. doi: 10.1038/nature24284. Epub 2017 Oct 23.

20.

Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.

Leal AD, Van Houten H, Sangaralingham L, Freedman RA, Jemal A, Neuman HB, Haddad TC, Mutter RW, Keegan THM, Mougalian SS, Loprinzi CL, Gross CP, Shah N, Ruddy KJ.

Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422-6. doi: 10.1016/j.clbc.2017.09.011. [Epub ahead of print]

PMID:
29054689
21.

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Kvale E, Lally RM, Langbaum TS, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, Freedman-Cass DA, McMillian NR.

J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.

22.

Thalidomide: Rebirth of a Gestational Antiemetic?

Ruddy KJ, Navari RM, Loprinzi CL.

J Clin Oncol. 2017 Nov 1;35(31):3523-3524. doi: 10.1200/JCO.2017.74.9663. Epub 2017 Sep 5. No abstract available.

PMID:
28872926
23.

Novel approaches to support breast cancer survivorship care models.

Gast KC, Allen SV, Ruddy KJ, Haddad TC.

Breast. 2017 Dec;36:1-13. doi: 10.1016/j.breast.2017.08.004. Epub 2017 Aug 29. Review.

PMID:
28843976
24.

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.

Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS.

Support Care Cancer. 2017 Nov;25(11):3537-3544. doi: 10.1007/s00520-017-3780-y. Epub 2017 Jun 20.

PMID:
28634656
25.

A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.

Pachman DR, Dockter T, Zekan PJ, Fruth B, Ruddy KJ, Ta LE, Lafky JM, Dentchev T, Le-Lindqwister NA, Sikov WM, Staff N, Beutler AS, Loprinzi CL.

Support Care Cancer. 2017 Nov;25(11):3407-3416. doi: 10.1007/s00520-017-3760-2. Epub 2017 May 27.

PMID:
28551844
26.

Management of Potential Long-Term Toxicities in Breast Cancer Patients.

O'Sullivan CC, Ruddy KJ.

Curr Breast Cancer Rep. 2016 Dec;8(4):183-192. doi: 10.1007/s12609-016-0229-0. Epub 2016 Oct 13.

27.

Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer.

Ruddy KJ, Van Houten HK, Sangaralingham LR, Freedman RA, Thompson CA, Hashmi SK, Jemal A, Haddad TC, Mougalian S, Herrin J, Gross C, Shah N.

Breast Cancer Res Treat. 2017 Aug;164(3):515-525. doi: 10.1007/s10549-017-4280-y. Epub 2017 May 10. Review.

PMID:
28493045
28.

Integrative medicine in cancer survivors.

Viscuse PV, Price K, Millstine D, Bhagra A, Bauer B, Ruddy KJ.

Curr Opin Oncol. 2017 Jul;29(4):235-242. doi: 10.1097/CCO.0000000000000376. Review.

29.

Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.

Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM.

Clin Lung Cancer. 2017 Sep;18(5):497-503. doi: 10.1016/j.cllc.2017.02.008. Epub 2017 Mar 2.

PMID:
28412094
30.

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS.

Breast Cancer Res Treat. 2017 Jun;163(3):535-544. doi: 10.1007/s10549-017-4199-3. Epub 2017 Mar 21.

31.

Risk of Heart Failure With Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.

Saiki H, Petersen IA, Scott CG, Bailey KR, Dunlay SM, Finley RR, Ruddy KJ, Yan E, Redfield MM.

Circulation. 2017 Apr 11;135(15):1388-1396. doi: 10.1161/CIRCULATIONAHA.116.025434. Epub 2017 Jan 29.

32.

Alternative Exercise Traditions in Cancer Rehabilitation.

Ruddy KJ, Stan DL, Bhagra A, Jurisson M, Cheville AL.

Phys Med Rehabil Clin N Am. 2017 Feb;28(1):181-192. doi: 10.1016/j.pmr.2016.08.002. Review.

PMID:
27912996
33.

Fit for Chemo: Nerves May Thank You.

Leon-Ferre R, Ruddy KJ, Staff NP, Loprinzi CL.

J Natl Cancer Inst. 2016 Oct 28;109(2). pii: djw208. Print 2017 Feb. No abstract available.

PMID:
27794125
34.

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).

Pachman DR, Qin R, Seisler D, Smith EM, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL.

Support Care Cancer. 2016 Dec;24(12):5059-5068. Epub 2016 Aug 18.

35.

Management of Hormone Deprivation Symptoms After Cancer.

Faubion SS, Loprinzi CL, Ruddy KJ.

Mayo Clin Proc. 2016 Aug;91(8):1133-46. doi: 10.1016/j.mayocp.2016.04.009. Review.

PMID:
27492917
36.

Randomized phase 2 trial of a coordinated breast cancer follow-up care program.

Ruddy KJ, Guo H, Baker EL, Goldstein MJ, Mullaney EE, Shulman LN, Partridge AH.

Cancer. 2016 Jul 26. doi: 10.1002/cncr.30206. [Epub ahead of print]

37.

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, Dietrich L, Biggs D, Lafky JM, Loprinzi CL.

N Engl J Med. 2016 Jul 14;375(2):134-42. doi: 10.1056/NEJMoa1515725.

38.

NCCN Guidelines Insights: Survivorship, Version 1.2016.

Denlinger CS, Ligibel JA, Are M, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Jones LW, King A, Ku GH, Kvale E, Langbaum TS, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Rodriguez MA, Ruddy KJ, Sanft T, Silverman P, Smith S, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jun;14(6):715-24.

39.

Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer.

Azim HA Jr, Davidson NE, Ruddy KJ.

Am Soc Clin Oncol Educ Book. 2016;35:23-32. doi: 10.14694/EDBK_159069.

40.

Scrambler Therapy for the management of chronic pain.

Majithia N, Smith TJ, Coyne PJ, Abdi S, Pachman DR, Lachance D, Shelerud R, Cheville A, Basford JR, Farley D, O'Neill C, Ruddy KJ, Sparadeo F, Beutler A, Loprinzi CL.

Support Care Cancer. 2016 Jun;24(6):2807-14. doi: 10.1007/s00520-016-3177-3. Epub 2016 Apr 4. Review.

41.

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH.

JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.

42.

A qualitative exploration of supports and unmet needs of diverse young women with breast cancer.

Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH.

J Community Support Oncol. 2015 Sep;13(9):323-9. doi: 10.12788/jcso.0169.

PMID:
26859752
43.

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators, Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Nevanlinna H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L, Platte R, Eeles R, Ellis S; EMBRACE, Hamann U, Garber J, Fostira F, Fountzilas G, Pasini B, Giannini G, Rizzolo P, Russo A, Cortesi L, Papi L, Varesco L, Palli D, Zanna I, Savarese A, Radice P, Manoukian S, Peissel B, Barile M, Bonanni B, Viel A, Pensotti V, Tommasi S, Peterlongo P, Weitzel JN, Osorio A, Benitez J, McGuffog L, Healey S, Gerdes AM, Ejlertsen B, Hansen TV, Steele L, Ding YC, Tung N, Janavicius R, Goldgar DE, Buys SS, Daly MB, Bane A, Terry MB, John EM, Southey M, Easton DF, Chenevix-Trench G, Antoniou AC, Ottini L.

Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y.

44.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).

Boora GK, Kanwar R, Kulkarni AA, Abyzov A, Sloan J, Ruddy KJ, Banck MS, Loprinzi CL, Beutler AS.

Cancer Med. 2016 Apr;5(4):631-9. doi: 10.1002/cam4.625. Epub 2016 Jan 14.

45.

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.

Ruddy KJ, Risendal BC, Garber JE, Partridge AH.

J Clin Oncol. 2016 Feb 20;34(6):539-41. doi: 10.1200/JCO.2015.63.5375. Epub 2015 Dec 28. No abstract available.

46.

The Epidemiology of Male Breast Cancer.

Ferzoco RM, Ruddy KJ.

Curr Oncol Rep. 2016 Jan;18(1):1. doi: 10.1007/s11912-015-0487-4. Review.

PMID:
26694922
47.

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Majithia N, Temkin SM, Ruddy KJ, Beutler AS, Hershman DL, Loprinzi CL.

Support Care Cancer. 2016 Mar;24(3):1439-47. doi: 10.1007/s00520-015-3063-4. Epub 2015 Dec 19. Review.

48.

Optimal delivery of male breast cancer follow-up care: improving outcomes.

Ferzoco RM, Ruddy KJ.

Breast Cancer (Dove Med Press). 2015 Nov 23;7:371-9. doi: 10.2147/BCTT.S75630. eCollection 2015. Review.

49.

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).

Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, Lafky JM, Wagner-Johnston ND, Ruddy KJ, Dakhil S, Staff NP, Grothey A, Loprinzi CL.

J Clin Oncol. 2015 Oct 20;33(30):3416-22. doi: 10.1200/JCO.2014.58.8533. Epub 2015 Aug 17.

50.

Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.

Shinde SS, Seisler D, Soori G, Atherton PJ, Pachman DR, Lafky J, Ruddy KJ, Loprinzi CL.

Support Care Cancer. 2016 Feb;24(2):547-553. doi: 10.1007/s00520-015-2807-5. Epub 2015 Jul 9.

PMID:
26155765

Supplemental Content

Loading ...
Support Center